Literature DB >> 7259595

Fluorophotometric study of epinephrine and timolol in human subjects.

H I Schenker, M E Yablonski, S M Podos, L Linder.   

Abstract

The action and interaction of topical 2% epinephrine hydrochloride and 0.5% timolol maleate therapy were studied in 12 normal and 16 ocular hypertensive subjects. Measurements of intraocular pressure, outflow facility, and aqueous secretion by fluorophotometry were made. Uveoscleral outflow values were calculated. Epinephrine, applied topically twice daily for one week, resulted in a decrease in IOP of 3.3 +/- 0.9 mm Hg and an increase in outflow facility of 0.05 +/- 0.01 microL/min/mm Hg, as well as an increase in the rate of aqueous production of 0.32 +/- 0.09 microL/min. Uveoscleral outflow showed an increase of 0.83 +/- 0.23 microL/min. Timolol, applied topically twice daily for one week, reduced the IOP 3.9 +/- 1.0 mm Hg and decreased aqueous flow 0.84 +/- 0.23 microL/min, but produced no change in outflow facility or uveoscleral flow. When epinephrine and timolol are given in combination, the effects in lowering IOP may not be completely additive.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259595     DOI: 10.1001/archopht.1981.03930020086007

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  17 in total

1.  Epinephrine effects on major cell types of the aqueous outflow pathway: in vitro studies/clinical implications.

Authors:  J A Alvarado; L Franse-Carman; G McHolm; C Murphy
Journal:  Trans Am Ophthalmol Soc       Date:  1990

2.  The role of prostaglandins in the para-aminoclonidine-induced reduction of intraocular pressure.

Authors:  R F Wang; C B Camras; S M Podos; K W Lee; K C Bhuyan; D K Bhuyan
Journal:  Trans Am Ophthalmol Soc       Date:  1989

Review 3.  Pharmacological therapy for glaucoma: a review.

Authors:  P F Hoyng; L M van Beek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 4.  [Suprachoroidal minimally invasive glaucoma surgery : Procedures and clinical outcome].

Authors:  C Erb
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

5.  Corneal endothelial permeability and aqueous humor flow using a standard protocol.

Authors:  J A van Best; M Diestelhorst; E Leite; S Fantaguzzi; R Schalnus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-09       Impact factor: 3.117

6.  Role of cyclic AMP-induced Cl conductance in aqueous humour formation by the dog ciliary epithelium.

Authors:  S Chen; R Inoue; H Inomata; Y Ito
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

Review 7.  The flow of aqueous humor in the human eye.

Authors:  R F Brubaker
Journal:  Trans Am Ophthalmol Soc       Date:  1982

Review 8.  Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension.

Authors:  M M Buckley; K L Goa; S P Clissold
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

9.  Intraocular pressure and aqueous humor flow during a euglycemic-hyperinsulinemic clamp in patients with type 1 diabetes and microvascular complications.

Authors:  James T Lane; Luann Larson; Shan Fan; Julie A Stoner; Eyal Margalit; Carol B Toris
Journal:  BMC Ophthalmol       Date:  2010-06-23       Impact factor: 2.209

10.  Long-term drift and timolol therapy: possible role for pulsed therapy.

Authors:  M Batterbury; S P Harding; D Wong
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.